Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data.
- DOI
- 10.1111/dom.12459
- Published
- 2015 Jun
- Container
- Diabetes, obesity & metabolism
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/dom.12459,
title = {Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data.},
author = {Del Prato S and Nauck M and Durán-Garcia S and Maffei L and Rohwedder K and Theuerkauf A and Parikh S},
year = {2015},
journal = {Diabetes, obesity \& metabolism},
doi = {10.1111/dom.12459},
url = {https://doi.org/10.1111/dom.12459}
}RIS
TY - JOUR TI - Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data. AU - Del Prato S AU - Nauck M AU - Durán-Garcia S AU - Maffei L AU - Rohwedder K AU - Theuerkauf A AU - Parikh S PY - 2015 JO - Diabetes, obesity & metabolism DO - 10.1111/dom.12459 UR - https://doi.org/10.1111/dom.12459 ER -
APA
S, D. P., M, N., S, D., L, M., K, R., A, T., & S, P. (2015). Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.12459
Source records
- pubmed · retrieved 2026-09-26T11:26:47.808Z